Discover 644 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 644
Epcoritamab and Rituximab for First-line Follicular Lymphoma
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Milwaukee WI, Indianapolis IN, St Louis MO, Gahanna OH,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase2, Phase3, Recruiting
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Location: Milwaukee WI, Madison WI, Iowa City IA, Columbus OH,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 19+
Code: NCT06974786
Phase2, Recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
for
Carcinoid Syndrome, Carcinoid, Carcinoid Tumor,
Location: Milwaukee WI, Iowa City IA, Rochester MN, Detroit MI,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT07087054
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Location: Milwaukee WI, Chicago IL, Rochester MN, Columbus OH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06876662
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Milwaukee WI, Oak Creek WI, New Berlin WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase2, Recruiting
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
for
COPD, Emphysema
Location: Milwaukee WI, Chicago IL, Peoria IL, Ann Arbor MI,
Sponsor: Apreo Health, Inc.
Sex: All
Age: 40 - 70+
Code: NCT06891755
Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Milwaukee WI, Madison WI, Chicago IL, Peoria IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Milwaukee WI, Madison WI, Chicago IL, Detroit MI,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT06787612
Phase2, Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for
Relapsing Multiple Sclerosis
Location: Milwaukee WI, Greenfield WI, Chicago IL, Owosso MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 40 - 70
Code: NCT06846281
Phase3, Recruiting
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
for
Lung Cancer (Diagnosis)
Location: Milwaukee WI, North Chicago IL, Dayton OH, DuBois PA,
Sponsor: bioAffinity Technologies Inc.
Sex: All
Age: 50 - 70+
Code: NCT07168993
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Location: Milwaukee WI, Chapel Hill NC, New York NY, New Haven CT,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Sex: All
Age: 18+
Code: NCT06656494
Phase1, Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
for
Castration-Resistant Prostate Carcinoma,
Location: Milwaukee WI, Oak Creek WI, Menomonee Falls WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06632977
Phase2, Recruiting
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
for
High Risk Pregnancy, Congenital Heart Disease, Fetal Hydrops,
Location: Milwaukee WI, Madison WI
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT03775954
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Location: Milwaukee WI, Evanston IL, Rock Island IL, Ann Arbor MI,
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 18+
Code: NCT05963698
Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Milwaukee WI, Madison WI, Chicago IL, St Louis MO,